Clear Harbor Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-60,330
| Closed | -$485K | – | 282 |
|
|
2018
Q2 | $485K | Hold |
60,330
| – | – | 0.09% | 144 |
|
|
2018
Q1 | $450K | Sell |
60,330
-1,680
| -3% | -$12.5K | 0.09% | 146 |
|
|
2017
Q4 | $369K | Sell |
62,010
-660
| -1% | -$3.93K | 0.07% | 163 |
|
|
2017
Q3 | $461K | Sell |
62,670
-9,260
| -13% | -$68.1K | 0.09% | 153 |
|
|
2017
Q2 | $493K | Buy |
71,930
+19,330
| +37% | +$132K | 0.09% | 145 |
|
|
2017
Q1 | $497K | Hold |
52,600
| – | – | 0.1% | 142 |
|
|
2016
Q4 | $454K | Sell |
52,600
-810
| -2% | -$6.99K | 0.1% | 142 |
|
|
2016
Q3 | $338K | Sell |
53,410
-2,850
| -5% | -$18K | 0.07% | 170 |
|
|
2016
Q2 | $237K | Sell |
56,260
-540
| -1% | -$2.28K | 0.05% | 210 |
|
|
2016
Q1 | $248K | Sell |
56,800
-50
| -0.1% | -$218 | 0.05% | 196 |
|
|
2015
Q4 | $348K | Sell |
56,850
-810
| -1% | -$4.96K | 0.08% | 170 |
|
|
2015
Q3 | $330K | Sell |
57,660
-120
| -0.2% | -$687 | 0.08% | 189 |
|
|
2015
Q2 | $431K | Buy |
57,780
+300
| +0.5% | +$2.24K | 0.08% | 177 |
|
|
2015
Q1 | $344K | Sell |
57,480
-2,070
| -3% | -$12.4K | 0.07% | 200 |
|
|
2014
Q4 | $450K | Sell |
59,550
-10,150
| -15% | -$76.7K | 0.09% | 176 |
|
|
2014
Q3 | $362K | Buy |
69,700
+47,600
| +215% | +$247K | 0.08% | 152 |
|
|
2014
Q2 | $95K | Buy |
22,100
+3,100
| +16% | +$13.3K | 0.02% | 210 |
|
|
2014
Q1 | $78K | Sell |
19,000
-1,000
| -5% | -$4.11K | 0.02% | 202 |
|
|
2013
Q4 | $107K | Buy |
+20,000
| New | +$107K | 0.03% | 175 |
|